AstraZeneca is launching a $1.5 billion cost-savings program to fund its drug pipeline Oct 30, 2026 · Cris Tolomia The drugmaker expects one-time restructuring costs of up to $2 billion as it redeploys resources over three years Read more »
.jpg?branch=production)
.jpg?branch=production)
.png?branch=production)
.jpg?branch=production)
